Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
New England Journal of Medicine (2021) - Comments
doi: 10.1056/nejmoa2102685  issn: 0028-4793  issn: 1533-4406  pubmed: 34260849 

Michael Dougan, Ajay Nirula, Masoud Azizad, Bharat Mocherla, Robert L. Gottlieb, Peter Chen, Corey Hebert, Russell Perry, Joseph Boscia, Barry Heller, Jason Morris, Chad Crystal, Awawu Igbinadolor, Gregory Huhn, Jose Cardona, Imad Shawa, Princy Kumar, Andrew C. Adams, Jacob Van Naarden, Kenneth L. Custer